PODD

Insulet Corporation

Price

$137.35

return (12m)

-57.55%

p/e

26.14

p/bv

6.90

DIVIDEND YIELD

0.00%

PODD price

Insulet

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PODD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-3.86%

3 months

-13.21%

1 year

-57.55%

2 years

-42.49%

5 years

-52.51%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals PODD

Valuation

P/E

26.14

Sector 1.14

Industry 3.38

P/BV

6.90

Sector 1.86

Industry 2.20

P/Revenue (PSR)

3.21

Sector 1.56

Industry 1.80

EV/EBITDA

64.23

Sector -48.05

Industry 2.35

EV/EBIT

77.21

Sector -27.46

Industry -3.67

P/EBITDA

15.03

Sector -32.50

Industry -53.91

P/EBIT

17.73

Sector -43.68

Industry -50.80

P/Total Assets

3.10

Sector 0.88

Industry 1.01

P/Net Current Assets

92.39

Sector -27.11

Industry -10.74

P/Working Capital

8.88

Sector 2.78

Industry 2.87

EPS

5.42

Sector -0.70

Industry -0.60

BVPS

20.52

Sector 4.34

Industry 5.06

Efficiency

Gross Margin

71.08%

Sector 49.36%

Industry 50.85%

EBITDA Margin

19.82%

Sector -283.40%

Industry -56.64%

EBIT Margin

16.49%

Sector -164.84%

Industry -55.50%

Operating Margin

16.89%

Sector -19.73%

Industry -25.35%

Net Profit Margins

12.29%

Sector -24.22%

Industry -28.78%

Asset Turnover

0.25

Sector 0.13

Industry 0.15

Profitability

ROE

26.39%

Sector -24.32%

Industry -22.56%

ROA

11.86%

Sector -24.41%

Industry -24.19%

ROIC

19.38%

Sector -529.97%

Industry -94.15%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

2.48

Sector 1.90

Industry 2.01

Net Debt / EBITDA

2.48

Sector -4.96

Industry -2.23

Net Debt / EBIT

2.98

Sector -3.08

Industry -1.54

Net Debt / Equity

0.28

Sector -0.45

Industry -0.28

Gross Debt / Equity

0.65

Sector -0.74

Industry -0.81

Equity/Assets

0.45

Sector 0.46

Industry 0.47

Liabilities/Assets

0.55

Sector 0.49

Industry 0.52

Growth

5Y Revenue CAGR

22.68%

Sector -

Industry -

5Y Earnings CAGR

86.13%

Sector -

Industry -

Fundamentals PODD

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Insulet ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$137.35

Fair Value

$50.02

Upside

-63.58%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PODD Insulet Corporation	$137.35	-57.99%	0.00%	26.14	6.90	26.39%	12.29%
ISRG Intuitive Surgical Inc.	$402.04	-9.45%	0.00%	44.01	7.60	17.26%	28.62%
ABT Abbott Laboratories	$101.51	-22.11%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$88.81	-3.46%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$44.04	-55.09%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$85.31	-27.36%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$222.83	-17.87%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$518.34	-17.35%	0.00%	35.48	25.07	70.67%	25.03%
COHR Coherent Inc.	$298.80	180.51%	0.00%	75.62	5.36	7.09%	11.19%
SYK Stryker Corp.	$274.78	-24.98%	1.26%	28.38	4.41	15.55%	14.43%
PHG Koninklijke Philips NV	$24.94	-5.39%	4.11%	18.19	1.78	9.80%	6.30%
INMD InMode Ltd.	$14.30	-4.38%	0.00%	10.90	1.34	12.32%	20.69%
DXCM DexCom Inc.	$87.23	29.23%	0.00%	33.89	12.92	38.14%	20.12%
BDX Becton Dickinson and Company	$182.56	1.11%	2.34%	52.21	2.01	3.86%	6.30%
EW Edwards Lifesciences Corp.	$86.45	15.79%	0.00%	50.69	4.74	9.36%	15.41%
ALGN Align Technology Inc.	$147.64	15.18%	0.00%	27.43	2.68	9.77%	9.99%
SNN Smith & Nephew PLC	$26.88	-22.45%	2.80%	19.48	4.52	23.22%	9.83%
IRMD iRadimed Corporation	$86.02	23.89%	1.54%	45.76	10.37	22.66%	26.70%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PODD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Insulet

Insulet Corporation

Average Investor10 user rating

4.0 (3 people)

United States

26 years

Founded: 2000

2007

Time since IPO - 19 years

1.350

Employees

Insulet Corporation (United States) is listed on the Nasdaq and has a market capitalization of $9.81 billion, with shareholders equity totaling $1.42 billion.

The company employs approximately 1.350 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Insulet Corporation reported $3.05 billion in revenue, generating net income of $375.30 million.

Key financial metrics include a P/E ratio of 26.14, a price-to-book (P/B) ratio of 6.90, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PODD.

Market cap

$9.81 billion

Net worth

$1.42 billion

$1,422,200,000.00

Assets

$3.17 billion

$3,165,100,000.00

Total Shares Outstanding

69.30 million

69,298,000

Average Daily Trading Volume

$1.70 million

$1,700,893.62

Sector

Health

Industry

Medical Supplies and Equipment

PODD

PODD revenue and profits

Financial Results PODD

DRAG THE FRAME TO SEE MORE DATA

PODD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.20 20,08% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$271.17 --3,11% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$62.80 80,15% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$412.62 64,54% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$40.94 --6,56% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,162.62 61,48% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$432.22 3,81% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$144.84 19,41% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35